propranolol + flunarizine Tablets, sustained release (SR) 40 mg + 10 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18161
This company operates in the pharmaceutical industry and has been in the market for a few decades, focusing on providing affordable healthcare solutions to the public. They are dedicated to offering quality products and services that exceed customer expectations. The company prioritizes research and development, aiming to become an integrated pharmaceutical industry with a strong focus on biotechnology and original drug research. Their commitment to social responsibility is reflected in their efforts to make quality medication accessible to all. The company manufactures a range of products, including prescription and over-the-counter medications, and has obtained GMP certifications for its production lines. Their main areas of focus include oncology and cardiology, with a diverse portfolio encompassing various dosage forms, including solids, injectables, and liquids. They hold patents for certain formulations and are active in several key regions including North America and the EU.
Propranolol is a beta-blocker class medication primarily used to treat high blood pressure, performance anxiety, various types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, and tremors. Suppliers market the drug as 50mg/5ml, 40mg/5ml, 10mg/5ml, and 5mg/5ml oral solution, as well as in the form of 10mg and 40mg propranolol tablets.
Propranolol was originally introduced into the market by manufacturer ICI pharmaceuticals (now a subsidiary of AstraZeneca). Currently, numerous manufacturing companies market both trade name and generic formulations of propranolol worldwide. Over 18 million prescriptions of the drug are registered annually in the U.S. alone, and the World Health Organization has included it in its list of Essential Medicines.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The main alternatives to propranolol for the treatment of high blood pressure include other beta-blocker class drugs, such as bisoprolol, nebivolol, carvedilol, and others.
The retail prices for 30 (40mg) propranolol tablets are around 6.00 EUR.